Abstract
We prolonged from 24 to 48 months a follow-up study of unipolar subjects with high recurrence rate treated with fluvoxamine (N=25) and sertraline (N=22). During the two-year additional period a significant risk of recurrences was observed during the third year of follow-up, without differences in the two long-term therapy groups. During the fourth year no patients showed new episodes of illness. Copyright (C) 2000 Elsevier Science B.V.
Original language | English |
---|---|
Pages (from-to) | 233-236 |
Number of pages | 4 |
Journal | Journal of Affective Disorders |
Volume | 58 |
Issue number | 3 |
DOIs | |
Publication status | Published - Jun 2000 |
Keywords
- Depression
- High recurrence
- Long-term treatment
- SSRIs
ASJC Scopus subject areas
- Psychiatry and Mental health
- Behavioral Neuroscience
- Biological Psychiatry
- Neurology
- Psychology(all)